Publikationen von Felipe Tapia
Alle Typen
Zeitschriftenartikel (8)
2021
Zeitschriftenartikel
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 2019
Zeitschriftenartikel
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology
Zeitschriftenartikel
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 2018
Zeitschriftenartikel
9, 26 (2018)
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in immunology 2017
Zeitschriftenartikel
12 (8), e0182553 (2017)
Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems. PLoS One 2016
Zeitschriftenartikel
100 (5), S. 2121 - 2132 (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and Biotechnology 2014
Zeitschriftenartikel
18 (3), S. 147 - 167 (2014)
Magnesium-containing bioactive polycrystalline silicate-based ceramics and glass-ceramics for biomedical applications. Current Opinion in solid state & materials science
Zeitschriftenartikel
32 (8), S. 1003 - 1011 (2014)
Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine Meeting Abstract (2)
2019
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , 06. Oktober 2019 - 10. Oktober 2019. (2019)
2017
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, 17. September 2017 - 21. September 2017. (2017)
Vortrag (14)
2020
Vortrag
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Plenarsitzung der Sächischen Akademie der Wissenschaften zu Leipzig, Leipzig, Germany (2020)
2019
Vortrag
Production of defective interfering particles of influenza A virus in continuously cultured bioreactors at two residence times - insights from within-host virus dynamics. 4th Workshop on Viral Dynamics, Paris, France (2019)
Vortrag
Moderne Methoden der Impfstoffherstellung. Wissenschaft im Rathaus, Magdeburg, Germany (2019)
Vortrag
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Cuba Symposium “Frontiers of Science”, Havanna, Cuba (2019)
Vortrag
Process Intensification in Viral Vaccine Manufacturing. International Symposium on Pharmaceutical Engineering Research – SPhERe, Braunschweig, Germany (2019)
Vortrag
A universal platform for continuous manufacturing of viral vaccines and gene therapy vectors. 5. Workshop Bio-Verfahrenstechnik, Fraunhofer CBP Leuna, Germany (2019)
Vortrag
A universal platform for continuous manufacturing of viral vaccines & gene therapy vectors. Workshop Bioverfahrenstechnik, Leuna, Germany (2019)
2017
Vortrag
A continuous tubular bioreactor for stable production of influenza virus vaccines. 25th ESACT Meeting, Lausanne, Switzerland (2017)
Vortrag
A continuous tubular bioreactor for stable production of influenza virus vaccines. CChIQ2017: National Conference of Chemical Engineering, Santiago, Chile (2017)
Vortrag
A continuous tubular bioreactor for stable production of influenza virus vaccines. SOMICH Coloquios de Microbiologia, Santiago, Chile (2017)